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1. INTRODUCTION
Pharmaceutical  chemistry  deals  with  the  chemistry  of  substances  used  as  a
therapeutic  agent  in  medicine.   It  embraces  the  main  branches  of  chemistry,
radiochemistry  analytical,  physical,  and  organic  chemistry.  Its  scope  expands  with
development,  in  medicinal  and  allied  studies,  and  the  emphasis  shifts  as  knowledge
advances.  On the other hand it is more narrowly concerned with isolation, determination
of  structure  and  synthesis  of  compounds  (mainly  organic),  which  may  be  used  in
medicine.  It also involves the study of metabolism, mechanism of action of drugs and
relationship between structure and biological activity [1]. 
Pharmaceutical analysis comprises those procedures necessary to determine the
“identity,  strength,  quality and purity”  of  the drug.   Again,  it  may be defined  as the
application of analytical procedures used to determine the purity, safety and quality of
drugs and chemicals.  It also deals with the analysis of raw materials and intermediates in
the  manufacture  of  drugs.   The  pharmaceutical  analyst  must  therefore,  have  a  firm
background in basic organic analysis and in addition he should have special skills in the
quality evaluation of drug products [2].  
Pharmaceutical  analysis  includes  both  qualitative  and  quantitative  analysis  of
drugs and pharmaceutical substances which starts from bulk drugs (starting materials to
the finished dosage forms) which is applied for identifying or quantifying constituents in
a sample [3].
 Qualitative analysis, which is concerned with the nature and the kind of material
in the sample, without a specific interest in the exact amounts present while.
 Quantitative analysis, which is concerned with the amounts of various materials in
the  sample  and  the  results  of  such  analysis  are  expressible  only  in  terms  of
numbers.
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Modern pharmaceutical  formulations are in multi-component  dosage forms for
the treatment of various diseases.  An accurate estimation procedure for each ingredient
in such multi-ingredient preparations is not an easy task, because of the complex nature
of drug and excipients added and it becomes more difficult when active constituents are
present in very small quantity.
The  increasing  emphasis  on  quality  control  and  the  complexities  of
pharmaceutical preparation have necessitated a pharmaceutical analyst to investigate and
adapt  newer techniques  which not only yield  accurate and precise result  but  also are
rapid.  Their requirement of analytical methods is usually met by instrumental methods
and hence during recent  year  trend is  to develop sensitive,  specific  and rapid method
using various sophisticated methods of analysis.
There  are  various  analytical  techniques  used  for  quantitative  analysis  and
qualitative analysis of mixtures. Various pharmaceutical analytical techniques, which are
being used can be categorized as follows [4]:
Spectral methods: 
Where we use light absorption or emission characteristics of drugs (eg) UV–VIS
Spectroscopy, IR Spectroscopy, NMR Spectroscopy, Flourimetry, etc.
 Chromatographic  methods:   Where  we  use  affinity  or  partition  coefficient
differences  between  drugs  (e.g.)  Thin  Layer  Chromatography  (TLC).   High
pressure liquid Chromatography (HPLC), Paper Chromatography, etc.
 Electro analytical techniques:  Based on the electrochemical property of drugs
(e.g.)  Potentiometry,  Conductometry,  Polarography,  Amperometry,  Paper
electrophoresis, etc.
 Biological  and  microbiological  methods:  Where  we  use  either  animals  or
microorganisms  for  analysis  (eg)  Biological  assay  of  some  vitamins,
microbiological assay of antibiotics and vitamins.
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 Radioactive methods: Like Radio Immuno assay and related techniques.
 Physical methods: Where we measure some physical characteristics of drugs. Eg.
Differential Thermal Analysis (DTA), Differential Scanning Calorimetry (DSC).
Thermo Mechanical Analysis (TMA).  Thermo Gravimetric Analysis (TGA), etc.
 Miscellaneous techniques:  Like conventional  titrimetric methods,  polarimetric
methods etc.
1.1. Chromatography [5, 6]
Chromatography is a method of chemical analysis and processing that is rapidly
replacing  some  of  the  more  traditional  techniques  of  sample  identification  and
purification. Modern pharmaceutical formulations are complex mixtures containing one
or more therapeutically active ingredients, to a number of inert materials like diluents,
disintegrates,  colors  and  flavors.  In  order  to  ensure  quality  and  stability  of  the  final
product, the pharmaceutical analyst must be able to separate the mixtures into individual
components prior to quantitative analysis.
History of chromatography
             Chromatography was first developed and defined by the Russian botanist
Mikhail  Tswett  (1892-1917)  in  1903.  He  produced  a  colorful  separation  of  plant
pigments using a column of calcium carbonate (Chalk). The word chromatography comes
from the Greek words for color “Chroma” and writes “graphein”.  So chromatography
means to write with colour. Some people state that mikahil Tswett, which invented the
term ‘chromatography’,  named the process after  him because ‘Tswett’  is  the Russian
word for ‘color’.
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Definitions for chromatography
 Tswett gave the first definition of chromatography. Chromatography is a method
in which the compounds of a mixture are separated on an adsorbent column in a
flowing system. 
 It  is the spatial  separation of the components of a complex molecular mixture
based on their differing affinities for distinct phase in relative motion. The various
forms of chromatography differ mostly on the type of phase that are being used
and,  resulting  from  that,  the  different  sorts  of   affinities  (ion  exchange,  size
exclusion, use of antibodies – immunosorbend) that are encountered.
 Chromatography is a separation method in which a mixture is applied as a narrow
initial zone to a stationary, porous absorbent and the components are caused to
undergo differential migration by the flow of the mobile phase, a liquid or a gas. It
does not fit  for  all chromatographic techniques and it  is  not  as concise as the
previous definition, but it highlights the most important concepts and is easy to
understand.
 One  of  the  most  widespread  definitions  is,  of  course,  the  one  from  the
Commission  on  Analytical  Nomenclature  of  IUPAC:  chromatography  is  a
physical  method  of  separation  in  which  the  compound  to  be  separated  are
distributed between  two phases.  One of  which is  stationary (stationary phase)
while the other (the mobile phase) moves in a definite direction (IUPAC, 1993).
1.1.2. Chromatography methods
General  chromatography  techniques  require  that  a  solute  undergo  distribution
between two phases,  one of them fixed (Stationary phase),  the other  moving (Mobile
phase). Chromatography involves a sample being dissolved in the mobile phase (can be
gas,  liquid or even supercritical  field).  This  mobile  phase is  then forced,  often under
Pressure, through an “immobilized” stationary phase. Solutes are separated by a dynamic
differential  migration  process  in  a  system  consisting  of  two  phases,  the  individual
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substance exhibit different mobilities by reasons of differences in adsorption, partition,
solubility, vapour pressure, molecular size or ionic  charge (Table 1).
Table - 1: Different chromatography methods
Liquid chromatography (LC) [7, 8]
It is analytical chromatography techniques that are useful for separating ions or
molecules  that  are dissolved in  a  solvent.  If  the sample solution is  in contact  with a
second solid or liquid phase, the different  solutes will interact with the other phase to
differing degrees due to differences in adsorption, iron exchange, partitioning, or size.
These differences allow the mixture components to be separated from each other by using
these differences to determine the transit time of the solutes through a column.
HPLC
High-performance  liquid  chromatography  (HPLC)  is  a  form  of  liquid
chromatography to quantify and analyze mixtures of chemical compounds.
Types of HPLC
HPLC is subdivided on the basis of separation chemistry. All of these techniques
can be used the same instrumentation.
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Name Mechanism StationaryPhase Mobile Phase
Paper Partition Liquid Liquid
Thin Layer Adsorption Solid Liquid
Gas Adsorption / Partition Liquid / solid Gas
Column Adsorption / Partition Liquid / solid Liquid
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Reversed - Phase chromatography 
In this type uses a non-polar (hydrophobic) stationary phase and a polar (usually
including some water) mobile phase. This is the most common type of HPLC separation
in use today.
Normal - phase chromatography 
In this type uses a polar (hydrophilic) stationary phase and a non-polar (usually
with  no  water)  mobile  phase.  This  was  the  type  of  separation  to  which  the  term
“Chromatography” was first applied.
Ion - exchange chromatography 
Uses  a  stationary phase  support  which has  been  derivatized permanently  bind
charged groups to the surface.  The mobile phase is  typically an aqueous buffer.  This
technique is used primarily for the analysis of ions such as strong acids or bases or for
separation of large molecules such as nucleic acids, proteins, or large peptides.
Ion - pair chromatography 
Ion  pair  chromatography  is  a  “hybrid”  technique  in  which  charge  groups  are
temporarily bound to the surface of a “reversed-phase” type  of column packing.  This
technique is often used for the analysis of small, weak-acid or weak-base compounds.
Size - exclusion chromatography 
Size - exclusion chromatography uses a stationary phase of controlled pore size
distribution. Separation is based on the extent to which analyte molecules can penetrate
the network of pores.
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Affinity chromatography 
Affinity chromatography operates using immobilized biochemical’s that have a
specific affinity to the compound of interest. Separation occurs as the mobile phase and
sample pass over the stationary phase. The sample compound or compounds of interest
are retained as the rest of the impurities and mobile phase through. 
Reverse phase chromatography
Mechanism
The  separation  mechanism  in  reverse  phase  chromatography  depends  on  the
hydrophobic binding interaction between the solute molecule in the mobile phase and the
immobilized  hydrophobic  ligand,  i.e.  the  stationary  phase.  Reversed  phase
chromatography  is  an  adsorptive  process  by  experimental  design,  which  relies  on  a
partitioning  mechanism  to  effect  separation.  The  solute  molecules  partition  (i.e.  An
equilibrium is established) between the mobile phase and the stationary phase.
Stationary phase
Any inert, non-polar substance that achieves sufficient packing can be used for
reversed-phase chromatography (Figure  1).  The most  popular  column is an octadecyl
carbon  chain  (C18)  bonded  silica  (USP  classification  L1)  with  297  columns
commercially available This is followed by C8 bonded silica (L7 - 166 columns), pure
silica (L3 - 88 columns), cyano bonded silica (L10 - 73 columns) and phenyl  bonded
silica (L11 - 72 columns). Note that C18, C8 and phenyl are dedicated reversed phase
packings  while  cyano  columns  can  be  used  in  a  reversed  phase  mode depending  on
analyte and mobile phase conditions. It  should be noted at this point that not all C18
columns have identical  retention properties.  Surface  functionalization of silica can be
performed  in  a  monomeric  or  a  polymeric  reaction  with  different  short-chain
organosilanes used in a second step to cover remaining silanol groups (end-capping).
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Figure - 1: Schematic diagram of stationary phase column
Mobile phase
Mixtures  of  water  or  aqueous  buffers  and  organic  solvents  are  used  to  elute
analytes from a reversed phase column. The solvents have to be miscible with water and
the most common organic  solvents  used  are acetonitrile,  methanol or  tetrahydrofuran
(THF).  Other  solvents  can  be  used  such  as  ethanol,  2-propanol  (iso-propyl  alcohol).
Elution  can  be  performed  isocratic  (the  water-solvent  composition  does  not  change
during the separation process) or by using a gradient (the water-solvent composition does
change during the separation process).
The pH of the mobile phase can have an important role on the retention of an
analyte  and  can  change  the  selectivity  of  certain  analytes.  Charged  analytes  can  be
separated  on  a  reversed  phase  column  by  the  use  of  ion-pairing  (also  called  ion-
interaction). This technique is known as reversed phase ion-pairing chromatography.
Reverse phase chromatography is widely in use due to the following advantages
Many compounds such as biologically active substance, have limited solubility in
non-polar solvent that are employed in normal phase chromatography (Table 2). Ionic or
high  polar  compounds  have  high  heats  of  adsorption  on  straight  silica  or  alumina
columns  and  therefore  can  elute  as  a  tailing  peaks.  Column deactivation  from polar
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modifiers is a problem in liquid – solid chromatography, which frequency can lead to
irreducibility in chromatography systems. 
Table - 2: Comparison of Normal Phase and Reverse Phase HPLC
Properties Normal phase Reverse phase
Polarity of stationary
phase
High Low
Polarity of mobile
phase
Low to medium Low to high
Sample elution order Leader polar first Most polar first
Retention will be
increased by
Increasing  surface  of   the
stationary phase
Increasing  surface   of  n-alkyl
chain length of stationary phase
Decreasing Polarity of  Mobile
phase
Increasing Polarity of  Sample
molecules
Increasing  surface  of
stationary surface
Increasing polarity of mobile
phase.
Deceasing polarity of sample
molecule
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1.1.3. Instrumentation of HPLC
Figure – 2: Schematic diagram of HPLC (waters instrumentation)
Solvent Reservoir
The reservoir that holes the mobile phase is often no more than a glass bottle. The
solvent is delivered from the reservoir to the pump means of Teflon tubing – called the
“inlet line” to the pump. Some HPLC systems have additional features that allow the
mobile phase to be degassed and isolated from contact with air.
Injectors for HPLC
Samples are injected into the HPLC via an injection port. The injection port of an
HPLC commonly consists  of  an  injection  valve  and  the  sample loop.  The  sample  is
typically dissolved in the mobile phase before injection into the sample loop. The sample
is then drawn into a syringe and injected into the loop via the injection valve. A rotation
of  the  valve  rotor  closes  the  valves  and  opens  the  loop  in  order  to  inject  between
10mcg/ml to over 500mcg/ml. In modern HPLC systems, the sample injection is typically
automated.
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Stopped  flow injection  (Figure  3  and  4)  is  a  method whereby  the pumps  are
turned  off,  allowing  the  injection  port  or  attain  atmospheric  pressure.  The  syringe
containing the sample is then injected into the valve in the usual manner, and the pump is
turned on. For syringe type and reciprocation pumps, flow in the column can be brought
to zero and rapidly resumed by diverting the mobile phase by means of a three-way valve
placed in front of the injector. This method can be used up to very high pressures.  
Figure – 3: Representative figure of sample load position
Figure - 4: Representative figure of sample inject position
HPLC Pumps
 There are several types of pumps available for use with HPLC analysis.
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Pumping system
The function of the pump in HPLC is to pass mobile phase through the column at a
controlled flow rate.  Features of an ideal pumping system include:
 Generating pressure from 6000 psi to 10000 psi.
 Pulse free output.
 Flow rates ranging from 0.1 to 10 ml/min.
 Flow control and reproducibility of 0.5% relative or better.
 Corrosion resistant components.
Classification of pumps
HPLC pump can be classified in to the following groups according to the manner in
which they operate:
Constant flow rate pump (or) constant displacement pump
Reciprocating piston pumps
Reciprocating Piston pumps are consist  of a small motor driven piston,  which
moves rapidly back and forth in a hydraulic chamber that may vary from 35-400mcg/ml
in volume. With the backstroke, the separation column valve is closed, and the piston
pulls is solvent from the mobile phase reservoir. On the forward stroke, the pump pushes
solvent out of the column from the reservoir. A wide range of flow rates can be attained
by altering the piston volume during each cycle, or by altering the stroke frequency. A
dual and triple head pump consists of identical piston chamber units, which operate at
180 or 120 degrees out of phase. This type system is significantly smoother because one
pump is filled while the other is in the delivery cycle.
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Syringe type pumps
Syringe type pumps are most suitable for small-bore columns because this pump
delivers only a finite volume of mobile phase before it has to be refilled.These pumps
have volume between 250 to 500ml. The pump operates by a motorized lead screw that
delivers mobile phase to the column at a constant rate. Changing the voltage on the motor
controls the rate of solvent delivery.
Constant pressure pumps
In  this  pump the  mobile  phase  is  driven  through  the  column with the use  of
pressure from a gas cylinder.  A low-pressure gas source is needed to generate high liquid
pressures. The valuing arrangement allows the rapid refill of the solvent chamber whose
capacity is about 70ml. This provides continuous mobile phase flow rates.
Displacement pump
Displacement pumps usually consist of large syringe like chambers equipped with
a plunger that is activated by a screw driven mechanism powered by stepping motors.
Displacement pumps also produce a flow that tends to be independent of viscosity and
backpressure.  In addition, the output is pulse free. Disadvantages include limited solvent
capacity (250 ml) and considerable inconvenience when solvents must be changed.
Pneumatic pumps
In  pneumatic  pumps,  the mobile  phase  is  contained  in  a  collapsible container
housed in a vessel that can be pressurized with a compressed gas.  Pumps of this kind are
inexpensive  and  pulse  free.   They  suffer  from  limited  capacity,  pressure  output,
dependence of flow rate on solvent viscosity and column backpressure.  In addition, they
are not amenable to gradient elution and are limited to pressures less than about 2000 psi.
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Sample injection system
 The limiting factor  in the precision of LC measurements  lie  in reproducibility
with which samples are introduced into the column packing. The earliest and simplest
means of sample introduction was syringe injection through a self-sealing electrometric
septum.  In stop flow injections, the flow of solvent is stopped momentarily, and fitting at
column head is removed and the sample is injected directly into the head of the column
packing.   After  replacing  the  fitting  the  system  is  again  pressurized.  Commercial
chromatographs  use  valves  for  sample  injection.   With these  devices,  sample is  first
transferred at atmospheric pressure from a syringe into a sample loop.  Turning the valve
from load to inject position connects the sample loop into the high-pressure mobile Phase
stream, whereby the contents of the sample loop are transferred on to the column. In
Rheodyne 7125 valve, sample from a micro liter syringe is loaded into the needle port,
filling the sample loop, which is a small piece of stainless steel tube connected between
ports.  Any excess goes  to waste from another port.  On turning to ‘inject’,  the loop
contents  are  flushed  on  to  the  column.   A  variety  of  loop  volumes  are  available,
commonly 10-50 µl.
Columns
The column (Figure 5) is one of the most important components of the HPLC
chromatograph because the separation of the sample components is achieved when those
components  pass  through  the  column.  Normally,  columns  are  filled  with  silica  gel
because  its  particle  shape,  surface  properties,  and  pore  structure  help  to  get  a  good
separation.  Silica  is  wetted  by  nearly  every  potential  mobile  phase,  is  inert  to  most
compounds and has a high surface activity which can be modified easily with water and
other agents. Silica can be used to separate a wide variety of chemical compounds, and its
chromatographic behaviors generally predictable and reproducible.
There  are  various  columns  that  are  secondary  to  the  separating  column  or
stationary  phase.  They  are  guard  (Figure  6),  derivatizing,  Capillary,  and  preparatory
columns
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Figure - 5: Representative figure of HPLC column
Figure – 6: Representative figure of Guard columns of HPLC
Guard columns are placed anterior  to the separating column. This serves  as  a
protective factor that prolongs the life and usefulness of the separation column.
They are dependable columns designed to filter or remove.
1. Particles that clog the separation column.
2. Compounds  and  ions  could  ultimately  cause  “baseline  drift”,  decreased
resolution, decreased sensitivity, and create false peaks.
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3. Compounds  that  may  cause  precipitation  upon  contact  with  the  stationary  or
mobile phase. 
4. Compound that  might  co-elute and  cause  extraneous  peaks  and  interfere  with
detection and / or quantification.
These  columns  must  be  changed  on  a  regular  basis  in  order  to  optimize  their
protective function. The size of the packing varies with the type of protection needed
(Table 3 and 4).
Derivatizing columns 
Pre  or  post  primary  column derivatization  can  be  an  important  aspect  of  the
sample  analysis.  Reducing  or  altering  the  parent  compound  to  a  chemically  related
daughter molecule or fragment elicits potentially tangible data, which may complement
other results or prior analysis.  In  a few cases,  the derivatization step to cause data to
become  questionable,  which  is  one  reason  why  HPLC  was  advantageous  over  gas
chromatography.  Because GC requires volatile, thermally stable, or nonpolar analytes,
derivatization  were  usually  required  for  those  samples,  which  did  not  contain  these
properties,  Acetylation,  Silylation,  or  concentrated  acid  hydrolysis  are  a  few
derivatization techniques.
Capillary columns 
Advances  in  HPLC  led  to  smaller  analytical  columns.  Also  known  as  micro
columns, capillary columns have a diameter much less than a millimeter and there are
three types: open – tubular, partially packed, and tightly packed. They allow the user to
work with nanonliter sample volumes, decreased flow rate, and decreased solvent volume
usage which may lead to cost effective.
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Microbore and small columns 
Bore Columns are also analytical and small volumes assays. A typical diameter of
a small – bore column is 1-2mm. Like capillary columns, instruments must usually be
modified to accommodate these smaller capacity columns (i.e. Decreased flow rate).
Fast columns 
One of the primary reasons for using these columns is to obtain improved sample
throughput (amount of compound per unit time). Fast columns are designed to decrease
time for the chromatographic analysis without forsaking significant deviations in results.
These columns have the same internal diameter but much shorter length than most other
columns,  and  they  are  packed  with  smaller  particles  that  are  typically  3  mcg/ml  in
diameter.  Advantages  include  increased  sensitivity,  deceased  analysis  time,  decreased
mobile phase usage, and increased reproducibility.
Preparative Columns 
These columns are utilized when the objective its prepares bulk (milligrams) of
sample for laboratory reparatory applications. A facilitate large volume injection into the
HPLC system. Accessories important to mention are the back-pressure regulator and the
fraction collector. The back-pressure regulator is placed immediately posterior to HPLC
detector. The fraction collector is an automated device that collects uniform increment of
the HPLC output.
Some bonded stationary phases for HPLC and column dimensions were presented
in table 3 and 4.
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Table - 3: Shown Bonded Stationary Phases for HPLC
Stationar
y
Functional
group
Application
Silica Si-OH Normal phase (Pesticides, alkaloids)
C18 Octadeyl Reverse phase (Fatty acid PAH Vitamins)
C8 Octyl Reverse-phase and ion pair (Peptides proteins)
C6H5 Phenyl Reverse phase (polar aromatic fatty acid)
CN Cyano Normal and reverse phase (polar compound)
NO2 Nitro Normal and Reverse-phase (PAH, Aromatic)
NH2 Amino Normal phase (weak ion exchange carbohydrates, Organic
acid, chlorinated pesticides)
Table - 4: Column dimensions
Type Internal Diameter(mm)
Length
(cm)
Particle size
(µm)
Analytical 0.3 - 0.46 3-28 3-10
Semimicro 0.1 – 0.21 10 – 25 3 – 18
Semipreparative 0.8 – 1.0 10 – 25 5 – 10
Preparative 2.0 – 5.0 10 – 25 10 – 20
J.K.K. Nattraja College of Pharmacy 18
Department of Pharmaceutical Analysis                                                           Introduction
Detectors
The detector  for  an  HPLC is  the compound that  emits  a  response  due  to  the
eluting sample compound and subsequently signals a peak on the chromatogram. It  is
positioned immediately posterior to the stationary phase in order to detect the compounds
as they elute from the column. The bandwidth and height of the peaks may usually be
adjusted  using  the  coarse  and  fine  tuning  controls,  and  the  detection  and  sensitivity
parameters may also be controlled (in most cases). There are many types of detectors that
can be used with HPLC.
Refractive Index (RI) detectors
RI detectors measure the ability of sample molecules to bend or refract light. This
property  for  each  molecule  or  compound is  called  its  refractive  index.  For  most  RI
detectors,  light  proceeds  throug33h  a  bi-modular  flow-cell  to  a  photo  detector.  One
channel of the flow-cell directs the mobile phase passing through the column while the
other directs only the mobile phase. Detection occurs when the light is bent due to the
samples  eluting  from  the  column,  and  this  is  read  as  a  disparity  between  the  two
channels.
Ultraviolet (UV) detectors
UV  detectors  measure  the  ability  of  a  sample  to  absorb  light.  This  can  be
accomplished at one or several wavelengths:
 Fixed Wavelength measures at one wavelength, usually 254 nm.
 Variable Wavelength measures at one wavelength at a time, but can detect
over a wide range of wavelengths.
 Diode Array measures a spectrum of wavelengths simultaneously.
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Fluorescence detectors
Fluorescence detectors are measuring the ability of a compound to absorb then re-
emits light at given wavelengths. Each compound has a characteristic fluorescence. The
excitation source passes through the flow-cell to a photo detector while a monochromatic
measures the emission wavelengths. Has a sensitivity limit of 10-9 to 10-11 gm/ml
Radiochemical detection
Involves the use of radio labeled material, usually tritium (3H) or carbon-14 (14C).
It operates by detection of fluorescence associated with beta-particle ionization, and it is
most popular in metabolite research. It is two types of detector as follows:
 Homogeneous- Where addition of scintillation fluid to column effluent causes
fluorescence.
 Heterogeneous- Where lithium silicate and fluorescence caused by beta-particle
emission interaction with the detector cell. Has a sensitivity limit up to 10-9 to 10-
10
 gm/ml.
Electrochemical detectors
Electrochemical detectors  are measure  compounds  that  undergo  oxidation  or
reduction reactions.  Usually accomplished by measuring the gain or loss  of  electrons
from migrating samples as they pass between electrodes at a given difference in electrical
potential. Has sensitivity of  10-12 to 10-13 gm/ml.
Mass Spectroscopy (MS) Detectors
The  sample  compound  or  molecule  is  ionized,  it  is  passed  through  a  mass
analyzer, and the ion current is detected. There are various methods for ionization
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 Electron Impact (EI) - An electron current or beam created under high electric
potential is used to ionize the sample migrating off the column.
 Chemical Ionization (CI) - A less aggressive method which utilizes ionizing gas
to remove electrons from the compounds eluting from the column.
 Fast Atom Bombardment (FAB) - Xenon atoms are propelled at high speed in
order to ionize the effluents from the column. Has a detection limit of 10-8 to 10-10
gm/ml.
Nuclear Magnetic Resonance (NMR) Detectors
Certain nuclei with odd- numbered masses, including H and  13C, spin about an
axis in a random fashion. However, when placed between the poles of a strong magnet,
the spins are aligned either parallel or anti-parallel to the magnetic field, with the parallel
orientation favored since it is slightly lower in energy. The nuclei are then irradiated with
electromagnetic radiation, which is absorbed and places the parallel nuclei into a higher
energy state; consequently, they are now in "resonance" with the radiation. Each H or C
will  produce different  spectra  depending on their location and adjacent  molecules,  or
elements in the compound, because all nuclei in molecules are surrounded by electron
clouds which change the encompassing magnetic field and thereby alter the absorption
frequency.
Light-Scattering (LS) Detectors
When a source emits a parallel beam of light which strikes particles in solution,
some light is reflected, absorbed, transmitted, or scattered. Two forms of LS detection
may be used to measure the two latter occurrences:
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 Nephelometry
This is defined as the measurement of light  scattered by a particulate solution.
This  method enables  the detection  of  the portion of  light  scattered  at  a  multitude  of
angles. The sensitivity depends on the absence of background light or scatter since the
detection occurs in a black or null background.
 Turbidimetry
This is defined as the measure of the reduction of light transmitted due to particles
in  solution.  It  measures  the light  scatter  as a decrease  in the light  that  is  transmitted
through the particulate solution. Therefore, it quantifies the residual light transmitted. The
sensitivity of this method depends on the sensitivity of the machine employed, which can
range from a simple spectrophotometer  to a sophisticated discrete  analyzer.  Thus, the
measurement of a decrease in transmitting light from a large signal of transmitted light is
limited to the photometric accuracy and limitations of the instrument employed.
Near-Infrared Detectors
Operates by scanning compounds in a spectrum from 700 to 1100 nm. Stretching
and bending vibrations of particular chemical  bonds in each molecule are detected at
certain  wavelengths.  This  is  a  fast  growing  method which offers  several  advantages:
speed  (sometimes less  than  1 second),  simplicity  of  preparation  of  samples,  multiple
analyses from single spectrum, and non consumption of the sample.
Applications of HPLC
Pharmaceutical applications
 Tablet dissolution study of pharmaceutical dosage form.
 Shelf-life determinations of pharmaceutical products.
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 Identification of active ingredients of dosage forms.
 Pharmaceutical quality control.
 Determination  of  partition  coefficients  and  pka  values  of  drugs  and  of  drug
protein binding.
Environmental applications
 Detection of phenolic compounds in Drinking Water.
 Identification of diphenhydramine in sediment samples.
 Bio-monitoring of pollutant.
Forensics
 Quantification of the drugs in biological samples.
 Identification of anabolic steroids in serum, urine, sweat, and hair.
 Forensic analysis of textile dyes.
 Determination of cocaine and metabolites in blood.
Clinical
 Quantification of ions in human urine.
 Analysis of antibiotics in blood plasma.
 Estimation of bilirubin and bilivirdin in blood plasma in case of hepatic disorders.
 Detection of endogenous neuropeptides in extracellular fluids of brain.
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Food and Flavor
 Ensuring the quality of soft drink and drinking water.
 Analysis of beer.
 Sugar analysis in fruit juices.
 Analysis of polycyclic compounds in vegetables.
 Trace analysis of military high explosives in agricultural crops.
Limitations of HPLC
 There  is  still  a  requirement  for  reliable  and  inexpensive  detectors  which  can
monitor compounds that lack a chromophore.
 Drugs have to be extracted from their formulations prior to analysis.
 Large amounts of organic solvent waste are generated, which are expensive to
dispose off.
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1.2. The basic steps involved in method development [9] 
1.2.1. Literature collection 
Search for literature (USP, EP, JP, IP, Chromatography Journals, patents, internet,
etc) for the same molecule or for similar molecules having similar structures.
Take the method from literature to check suitability to meet the requirements or
modify the method to suit the requirements such are resolution of possible impurities as
per the synthetic process.
1.2.2. Chemical structure 
By  observing  the  structure,  based  on  the  functional  groups  present  in  the
molecule, it can be determined whether the compound is Basic, acidic and neutral.  Based
on the nature of the compound, the pH of the mobile phase can be selected.
If  the  compound  is  acidic,  acidic  mobile  phase  is  preferable.   For  a  basic
compound,  low pH and  basic  mobile  phases  are  preferable.  For  a  neutral  compound
neutral mobile phase is suitable. Elution of the compounds will follow on ‘like solves
like’ concept.
1.2.3. Molecular weight 
If the molecular weight is less than 500 and based on the solubility and nature
(acid/base/ionic/non-ionic) of the molecule we can select the techniques given below.
Reversed  phase chromatography (for  acids,  bases  and non-ionic samples)  Ion-
pair  chromatography  (for  ionic  samples),  Ion  exchange  chromatography  (for  ionic
samples)  Normal  phase  chromatography  (for  isomers,  non-polar/non-ionic  samples,
chiral molecules) Size exclusion  chromatography  (for protein related samples)Capillary
electrophoresis (for red-ox  samples)
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1.2.4. pH   / pKa value of compounds
Based on pH / pKa values the nature of the compound (acidic, basic and neutral in
nature) and polarity of the compound can be assumed.
1.2.5. Sample solubility
Check  the  solubility  of  all  components  in  the  solutions  like  organic  mixtures,
aqueous-organic mixtures and mixtures of mineral acids like perchloric acid, phosphoric
acids, and buffer solution etc.
1.3. Optimization of chromatographic condition
Optimization  can  be  started  only  after  a  reasonable  chromatogram  has  been
obtained.  A reasonable  chromatogram means  that  all  the compounds are  detected  by
more or less symmetrical peaks on the chromatogram. By a slight change of the mobile
phase composition, the shifting of the peaks can be expected. From a few experimental
measurements,  the  position  of  the  peaks  can  be  predicted  within  the  range  of
investigating changes. An optimized chromatogram is the one in which all the peaks are
symmetrical and are well separated in less run time. [10-12]
The  peak  resolution  can  be  increased  by  using  a  more  efficient  column with
higher theoretical plate number, N.
The parameters that are affected by the changes in chromatographic conditions
are,
 Resolution (Rs),
 Capacity factor (k’),
 Selectivity (α),
 Column efficiency (N) and
 Peak asymmetry factor (As).
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Retention time (tR)
Retention  time  is  the  difference  in  time  between  the  point  of  injection  and
appearance of peak maxima. Retention time is the time required for 50% of a  component
to be eluted from  a column. Retention time is measured in minutes of seconds. Retention
time is also proportional to the distance moved on a chart paper, which can be measured
in cm or mm.
Retention volume (VR)
Retention volume is the mobile required to elute 50% of the component from the
column. It is the product of retention time and flow rate. Retention Volume = Retention
time x flow rate
Resolution 
Resolution is a measure of the separation of the two components and the baseline
separation achieved. Resolution is generally defined as “the distance between the centers
of two eluting peaks as measured by retention time or volume divided by the average
width of  the respective  peaks  “Resolution can  be  determined  by using the  following
formula
Rs = 
t1 and t2 – Retention times of two components.
w2  and  w1 –  Width  of  the  two  components  at  the  bases  of  the  peaks  obtained  by
extrapolating the relatively straight sides of the peaks to the baseline.
The parameters that contribute to a peak resolution column selectively,   Column
efficiency and the column retention factor.
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 * *
Resolution Rs is a function of selectivity a, efficiency (Number of theoretical plates) and
the average retention factor, K’ for peaks 1 and 2.
Capacity factor
The  capacity  factor,  K’  is  related  to  the  retention  time  is  a  reflection  of  the
proportion time of a particular solute residue in the stationary phase as opposed to the
mobile phase. Long retention times results in large valves of K’. The capacity factor K’,
can  be  calculated  for  every  peak  defined  in  a  chromatogram,  using  the  following
equations.
                          
*
               Where TR are the retention time and retention volume, respectively, of the
solute and TO and VO the retention time and retention volume, respectively,  of an un
retarded solute.
Efficiency (N)
The number of theoretical plates expresses the efficiency of a packed column; N.
‘N’ is  also called as  number of  theoretical  plates  count.  It  is  a  measure  of  the band
spreading of a peak. Smaller the band spread, higher the theoretical plate indicates good
column and system performance. A theoretical plate is an imaginary or hypothetical unit
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of a column where an equilibrium has been established between stationary phase and
mobile phase.
The column plate number N is calculated by
   N   =    16 Rt  2 
                                    W2 
Where 
N = Number of theoretical plates
Rt = Retention time 
W = peak width at base 
                Mutual measurement of the baseline bandwidth ‘W’ may be subject to error.
Therefore, a more practical equation for N is
N = 5.54     [t/ Wh/2] 2
Wh/2 is the width of peak half height.
The number of theoretical  plates is sometimes reported as plates per meter of column
length (N/L). The height equivalent to theoretical plates, H, is given by
H = L/N
Where L is column length and N is the number of theoretical plates.
Asymmetry factor (or) tailing factor (T)
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T= 
The assessment of peak shape is in terms of asymmetry factors.
1.4. Validation of analytical method [13]
Validation  is  the  documented  evidence,  which  provides  a  high  degree  of
assurance  for  specific  method.  Validation  is  a  systemic  approach  to  identifying,
measuring,  evaluating,  documenting,  and  evaluating  all  the  critical  steps  responsible,
before establishing the validity of the method. Validation of the analytical method is not
only an integral part of quality control system, but cGMP also require assay validation. 
FDA defines validation as “establish the documented evidence which provides a
high degree of assurance that a specific process will consistently produce a product of
predetermined specifications and quantity attributes”.
Analytical method validation includes all the procedures and checks required to
prove the reliability of a method for quantitative determination of concentration of an
analyte or series of analytes in a given sample. For analytical  method validation, US-
FDA has given some guidelines in USP and are referred as “Eight steps of analytical
method  validation”. These  terms  are  also  referred  as  “Analytical  Performance
Parameters”. 
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Figure - 7: Eight steps of method validation
Specificity
It  is the ability of an analytical  method to assess unequivocally the analyte of
interest  in  the  presence  of  components  that  may be  expected  to  be  present,  such  as
impurities,  degradation  products  and  matrix  components.  In  the  case  of  the  assay,
demonstration of specificity requires that the procedure is unaffected by the presence of
impurities or excipients. In practice, this can be done by spiking the drug substances or
product with appropriate levels of impurities or excipients, and demonstrating that the
assay is  unaffected  by the  presence  of  these extraneous  materials.  If  the degradation
product  impurity  standards  are  unavailable,  specificity  may  be  demonstrated  by
comparing the test results of samples containing impurities or degradation products to a
second well-characterized procedure. These comparisons should include samples stored
under  relevant  stress  conditions  (e.g.  Light,  heat,  humidity,  acid/base  hydrolysis,
oxidation, etc.).
Linearity and range 
The linearity of an analytical method is its ability to obtain test results in direct or
well-defined mathematical transformation proportional to the concentration of analyte in
samples  within a  given  range.  It  should be established across  the range  of  analytical
procedure. Linearity is generally represented as the correlation coefficient, the slope of
the regression line, etc. The range is normally expressed in the same unit as test results
(e.g. Percentage, ppm, ppb, etc.).
Precision 
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 The  precision  of  an  analytical  method  is  the  degree  of  agreement  among
individual  test results  when the method is  applied repeatedly to multiple sampling of
homogenous sample. The precision of an analytical method is determined by assaying
sufficient number of aliquots of a homogenous sample to be able to calculate statistically
valid estimates of standard deviation or related standard deviation.
Accuracy
It  is defined as the closeness of agreement between the actual (true) value and
mean analytical value obtained by applying a test method number of times. The accuracy
of an  analytical  method is  determined  by systematic  error  involved.  The accuracy  is
acceptable if the difference between the true value and mean measured value does not
exceed the RSD values obtained for repeatability of the method. The parameter provides
information  about  the  recovery  of  the  drug  from a  sample  and  effect  of  matrix,  as
recoveries are likely to be excessive as well as deficient.
Limit of detection (LOD)
It is the lowest amount of analyte in the sample that can be detected, but hasn't
necessarily constituted under the stated experimental conditions. Thus, limit test merely
substantiates that the amount of analyte is above or below a certain level. The detection
limit is usually expressed as the concentration of analyte (e.g. Percentage, ppm, ppb, etc.)
in the sample.
Based on the standard deviation of the response and the quantitation limit may
expressed as
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σ = The standard deviation of the response
S = The slope of the calibration curve (of the analyte)
Limit of quantitation (LOQ)
 The limit of quantitation is the lowest amount of analyte in the sample that can be
determined  with  acceptable  precision  and  accuracy  under  the  stated  experimental
conditions.  It is usually expressed as the concentration of analyte (e.g. Percentage, ppm,
ppb, etc.) in the sample.
Based on the standard deviation of the response and the quantitation limit may expressed
as                              
LOQ = 
Where
σ = The standard deviation of the response.
S = The slope of the calibration curve (of the analyte).
Figure – 8: Representative figure of limit of detection and limit of
quantitation via signal to noise
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Ruggedness
The ruggedness of an analytical  method is the degree of reproducibility of test
results obtained by the analysis of the same samples under a variety of conditions such as
different laboratories, different analysts, different instruments, different lots of reagents,
different elapsed assay times, different assay temperatures, different days, etc.
Robustness
The  robustness  of  analytical  method  is  a  measure  of  its  capacity  to  remain
unaffected  by  small  but  deliberate  variations  in  method  parameters  and  provides  an
indication of its reliability during normal usage.
Stability test
The term “Stability” can be defined as the product’s ability to maintain its various
properties and characteristics within the prescribed limits, from the time of the products
manufacture until its self life. One of the main reasons for conducting the stability test is
product reflects  its  efficacy,  quality and safety aspects  evaluation of  product stability
gives a rough measure of such aspects.
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2. REVIEW OF LITERATURE
Maria-Cristina Ranetti et al., (2009) reported the development and validation of
a simple HPLC method for  the simultaneous determination of  metformin (MTF)  and
gliclazide (GCZ) in the presence of  glibenclamide,  in  human plasma, for  the clinical
monitoring of MTF and GCZ after oral administration or for bioequivalence studies. Ion-
pair separation followed by UV detection performed on deproteinised plasma samples
was chosen for the determination of metformin and gliclazide. The internal standard was
glybenclamide.  The HPLC method used a Zorbax Eclipse XDB-C18 150x4.6 mm i.d.
(5µm) column and analytical guard column 12.5x4.6 mm (5µm), with a gradient elution
(1 mL/min) at 40°C column temperature. The mobile phase was acetonitrile: methanol
(1:1v/v)  and  sodium dodecylsulphate  5mM,  pH=3.5  with  H3PO4  85%  and  gradient
elution. The eluent was monitored at 236 nm. The calibration curve was linear within the
range of 0.05-5.00 µg/mL (r2=0.99, n=6). The lowest limit of quantification (LLOQ) was
50  ng/mL  for  metformin  and  49  ng/mL  for  gliclazide.  The  proposed  method  was
validated and proved to be adequate for metformin and gliclazide clinical monitoring,
bioavailability and bioequivalence studies.[14]
Mubeen  and  Khalikha  Noor  et  al., (2009) reported  a  simple  and  sensitive
spectrophotometric  method  has  been  developed  and  validated  for  the  estimation  of
metformin hydrochloride in bulk and in tablet formulation. The primary amino group of
metformin  hydrochloride  reacts  with  ninhydrin  in  alkaline  medium to  form  a  violet
colour  chromogen,  which is  determined  spectrophotometrically  at  570 nm. It  obeyed
Beer's law in the range of 8-18 µg/ml. Percentage recovery of the drug for the proposed
method ranged from 97-100% indicating no interference of  the tablet  excipients.  The
proposed  method  was  found  to  be  accurate  and  precise  for  routine  estimation  of
metformin hydrochloride in bulk and from tablet dosage forms.[15]
Sujana et  al.,  (2010) reported  two new UV-spectrophotometric  methods have
been  developed  for  simultaneous  estimation  of  Pioglitazone hydrochloride  and
Metformin  hydrochloride  in  tablets.  The  first  method  was  based  on  application  of
vierodt’s method which involves the formation and solving of simultaneous equations at
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225nm and 237nm, as absorbance maxima of Pioglitazone hydrochloride and Metformin
hydrochloride,  respectively.  The  second  method  employed was  absorption  correction
method which involves direct estimation of pioglitazone hydrochloride at 267 nm, as at
this  wavelength  Metformin  hydrochloride  has  zero  absorbance  and  shows  no
interference.  For  estimation  of Metformin  hydrochloride,  corrected  absorbance  was
calculated  at  237.0  nm due  to  the  interference  of  Pioglitazone hydrochloride  at  this
wavelength.  Calibration curves  were linear  with correlation coefficient  between 0.999
over the concentration range of 6-14 µg/mL and 1-5 µg/mL for both the drugs. The mean
percent recovery was found in the range of 99.41-99.80 and 100.36-100.52 for vierodt’s
method  and  99.18-99.80  and  99.64-99.92  for  absorption  correction  method,  for
pioglitazone  hydrochloride  and Metformin  hydrochloride,  respectively.  The  results  of
analysis were validated statistically. The proposed methods are simple, rapid, accurate,
precise  and  economical  and  can  be  used  successfully  in  the  quality  control  of
pharmaceutical formulations and routine laboratory analysis.[16]
Prachi  Saxena  et  al.,  (2010) reported  a  sensitive  and  accurate  UV
spectrophotometric method for the determination of metformin hydrochloride in tablet
dosage  form has  been  evolved.  The  various  parameters,  such  as  linearity,  precision,
accuracy,  limit  of  detection  and  limit  of  quantitation  were  studied  according  to
International  Conference  on Harmonization  guidelines  (ICH).The  method  is  accurate,
precise  (%  CV=0.763)  and  linear  within  the  range  1-16  µg/mL  with  coefficient  of
correlation, R2 = 0.9995. The limit of detection and limit of quantitation were found to be
22.34 and 67.69 ng/mL respectively. The proposed method was successfully employed
for the quantitative determination of metformin tablet dosage form with no interference
from any other excipients and diluents.[17]
Dhabale et al., (2010)  reported two simple, accurate, precise, reproducible and
economical  procedures  for  simultaneous  estimation  of  Gliclazide  and  Metformine
hydrochloride in tablet dosage form have been developed. First method based on solving
of simultaneous equation using 228 nm (λmax of GLZ) and 234 nm (λmax of MET) as
two analytical  wavelengths for both drugs in mixture of Water and Methanol (60:40)
solvent.  Second  method  based  on  an  equation  of  area  calculation  of  curve  at  two
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wavelength  resion (233 to 223nm and 239 to 229 nm).Linearity was observed  in the
concentration  range  of  2-24 µg/ml  for  GLZ and 2-14 µg/ml  for  MET. The result  of
analysis have been validated satistically and by recovery study.[18]
Madhukar  et  al.,  (2011)  reported a  simple,  specific,  accurate  and  isocratic
reversed  phase  -  HPLC  method  was  developed  and  subsequently  validated  for  the
determination of Metformin Hydrochloride. Separation was achieved with an Inertsil  -
Extend - C18 HPLC column 250mm in length and having an internal diameter of 4.6mm.
A mobile phase comprising 10m.mol 1-Octane sulfonic acid: Acetonitrile in the volume
ratio of (80:20) was developed. The detection was carried out using a PDA detector set at
a wavelength of 232nm. Validation experiments were performed to demonstrate System
suitability,  specificity,  precision,  linearity  and  Range,  Accuracy  study,  stability  of
analytical solution and robustness. The method was linear over the concentration range of
1-250µg/ml  and  get  the  correlation  Regration  (R2)  0.9995,  showed  good  recoveries
(100.25 - 101.13%), the relative standard deviations of intra and inter-day assay were
99.4% and 99.94% respectively.  The method can be used for quality control assay of
Metformin Hydrochloride.[19]
Havele and Dhaneshwar S,et al., (2011) reported a simple, rapid, and precise
reversed-phase  high-performance  liquid  chromatographic  method  for  simultaneous
analysis  of  metformin  hydrochloride,  gliclazide,  and  pioglitazone  hydrochloride  in  a
tablet dosage form has been developed and validated. Chromatography was performed on
a 25 cm × 4.6 mm i.d., 5µm particle, C18 column with 85:15 (v/v) methanol: 20 mM
potassium dihydrogen phosphate buffer as mobile phase at a flow rate of 1.2 ml/min. UV
detection at 227 nm; metformin hydrochloride, gliclazide, and pioglitazone hydrochloride
were eluted with retention times of 2.15, 3.787, and 4.57 min, respectively. The method
was  validated  in  accordance  with  ICH guidelines.  Validation  revealed  the  method  is
specific, rapid, accurate, precise, reliable, and reproducible. Calibration plots were linear
over the concentration ranges 50– 250 mg/ml for  metformin hydrochloride,  3.0 –15.0
mg/ml for gliclazide, and 2–10 mg/ml for pioglitazone hydrochloride. Limits of detection
were 0.20, 0.04, and 0.10 mg/ml and limits of quantification were 0.75, 0.18, and 0.30
mg/ml  for  metformin  hydrochloride,  gliclazide,  and  pioglitazone  hydrochloride,
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respectively. The high recovery and low coefficients of variation confirm the suitability
of the method for simultaneous analysis of the three drugs in tablets. Statistical analysis
proves that the method is suitable for the analysis of metformin hydrochloride, gliclazide,
and pioglitazone hydrochloride as a bulk drug and in pharmaceutical formulation without
any interference from the excipients. It may be extended to study the degradation kinetics
of three drugs and also for its estimation in plasma and other biological fluids.[20]
Ramzia  I.  El-Bagary  et  al.,   (2012),  In  this  work,  a  reversed-phase  liquid
chromatographic (RP-LC) method has been developed for the determination of alogliptin
(ALG)  based  on  isocratic  elution  using  a  mobile  phase  consisting  of  potassium
dihydrogen phosphate buffer pH (4.6) - acetonitrile (20:80,  v/v) at a flow rate of 1 mL
min−1 with  UV detection at  215 nm.  Chromatographic  separation  was achieved  on a
Symmetry®  cyanide  column  (150  mm  ×  4.6 mm,  5  µm).  Linearity,  accuracy  and
precision were found to be acceptable over the concentration range of 5-160 µg mL−1 for
ALG in bulk. The optimized method was validated and proved to be specific, robust and
accurate for the quality control of ALG in pharmaceutical preparations.[21]
Amruta B. Loni ea al.,  (2012) reported two simple, precise and economical UV
methods have been developed for the simultaneous estimation of Sitagliptin phosphate
and  Metformin hydrochloride  in  bulk  and  pharmaceutical  dosage  form.  Method A is
Absorbance maxima method, which is based on measurement of absorption at maximum
wavelength  of  266  nm  and  232  nm  for  Sitagliptin  phosphate  and  Metformin
hydrochloride  respectively.  Method  B is  area  under  curve  (AUC),  in  the  wavelength
range  of  244-279  nm  for  Sitagliptin  phosphate  and  222-240  nm  for  Metformin
hydrochloride. Linearity for detector response was observed in the concentration range of
25-225µg/ml for Sitagliptin phosphate and 2-12 µg/ml for Metformin hydrochloride. The
accuracy of the methods was assessed by recovery studies and was found to be 99.64 %
and  98.98%  for  Sitagliptin  phosphate  and  Metformin  hydrochloride.  The  developed
method  was  validated  with  respect  to  linearity,  accuracy  (recovery),  precision  and
specificity. The results were validated statistically as per ICH Q2 R1 guideline and were
found  to  be  satisfactory.  The  proposed  methods  were  successfully  applied  for  the
J.K.K. Nattraja College of Pharmacy 38
Department of Pharmaceutical Analysis                                                 Review of Literature
determination of for Sitagliptin phosphate and Metformin hydrochloride in commercial
pharmaceutical dosage form.[22]
Joshi  et  al., (2012)  reported  a  simple,  rapid,  precise,  and  accurate,  stability-
indicating  reversed  phasehigh  performance  liquid  chromatographic  method  was
developed  and  validated  for  si-multaneous  determination  of  metformin  HCl  and
repaglinide.  The  chromatographicseparation  was  achieved  on  YMC  Pack  AM  ODS
(5µm, 250 mm length × 4.6 mm i.d.)column at a detector wavelength of 210 nm, using an
isocratic  mobile  phase  consisting  ofmethanol  and  10  mM  potassium  dihydrogen
phosphate  buffer  (pH 2.5)  in  a  ratio  of  70:30v/vat  a  flow rate  of  1  mL min–  1.  The
retention  times  for  metformin  and  repaglinide  werefound  to  be  2.6  and  11.3  min,
respectively. The drugs were exposed to thermal, photo-lytic, hydrolytic, and oxidative
stress  conditions,  and  the  stressed  samples  were  ana-lyzed  by  the  proposed  method.
Validation  of  the  method  was  carried  out  as  per  Interna-tional  Conference  on
Harmonization (ICH) guidelines. Linearity was established formetformin and repaglinide
in the range of 5–200µg mL−1and 1–200µg mL−1, respec-tively. The limits of detection
were  0.3µg mL−1and 0.13µg mL−1for  metformin and  re-paglinide,  respectively.  The
method  was  found  to  be  specific  and  stability-indicating  asno  interfering  peaks  of
degradants  and  excipients  were  observed.  The  proposed  methodis  hence  suitable  for
application  in  quality-control  laboratories  for  quantitative  analysisof  both  the  drugs
individually and in combination,  since it  is simple and rapid with good accuracy and
precision.[23]
Usharani  Gundala  et  al.,  (2013)  reported  a  simple,  accurate,  precise  and
reproducible method has been developed for the simultaneous estimation of Vildagliptin
and Metformin hydrochloride in combined tablet dosage forms. As there are no reported
UV  methods  for  the  simultaneous  estimation  of  Vildagliptin  and  Metformin
hydrochloride in their combined dosage form, a need was felt to develop new methods to
analyze  the  drugs  simultaneously.  The  estimation  was  done  by  multi-wavelength
technique,  at  wavelengths  of  217  nm and  234  nm over  the  concentration  ranges  of
0.7µg/ml  and  7  µg/ml  with  mean  recovery  100%  for  both  drugs  Vildagliptin  and
Metformin  hydrochloride  respectively.  The  results  of  the  analysis  were  validated
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statistically  and  recovery  studies  were  carried  out  as  per  ICH  guide  lines.  Thus  the
proposed  method  can  be  successfully  applied  for  the  simultaneous  estimation  of
Vildagliptin and Metformin hydrochloride in routine analysis work.[24]
Sujani  et  al.,  (2013)  reported a  simple,  sensitive,  rapid,  economic,  UV
Spectroscopic method was developed for the estimation of Sitagliptin-Metformin in Pure
and Tablet dosage forms. The linearity for Metformin was found between 200-400 µ/ml
and between 20-45 µg/ml for Sitagliptin. Metformin showed the maximum absorbance at
232nm & Sitagliptin at 266nm and Validation parameters like Precision, Accuracy, and
System  suitability  parameters  were  determined  and  examined  by  applying  validated
parameters. [25]
Himal  Paudel  Chhetri  et  al.,  (2013) reported  the  optimization  of  a  simple
HPLC-UV  method  for  the  determination  of  metformin  in  human  plasma.  Ion  pair
separation followed by UV detection was  performed on deproteinized human plasma
samples. The separation was carried out on a Discovery Reversed Phase C-18 column
(250 X 4.6 mm, 5µm) with UV detection at 233 nm. The mobile phase contained 34%
acetonitrile and 66% aqueous phase. Aqueous phase contained 10 mM KH2PO4 and 10
mM sodium lauryl sulfate. Aqueous phase pH was adjusted to 5.2. The mobile phase was
run isocraticcally. The flow rate of the mobile phase was maintained at 1.3 ml/min. The
linearity of the calibration curve was obtained in the concentration range of 0.125–2.5
µg/ml and coefficient of determination (R2) was found to be 0.9951. The lowest limit of
quantification  and  detection  was  125  and  62  ng/ml  respectively.  No  endogenous
substances  were found to interfere with the peaks of  drug and internal  standard.  The
intra-day and inter-day coefficient of variations was 6.97% or less for all the selected
concentrations. The relative errors at all the studied concentrations were 5.60% or less.
This method is time efficient and samples are easy to prepare with minimum dilution. So,
it can be applied for monitoring metformin in human plasma. [26]
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3. RESEARCH ENVISAGED
The number of drugs and drug formulations are introduced into the market has
been  increasing at  an  alarming rate.  These  drugs  or  formulations  may be either  new
entities in the market  or partial  structural  modifications of the existing drug or novel
dosage forms.
Standard  analytical  procedures  for  the  estimation  of  these  drugs  are  most
necessary for the development of newer analytical  methods which are more accurate,
precise, specific, linear, simple and rapid. The modern method of choice of analysis is
HPLC,  which  requires  highly  sophisticated  equipment,  trained  personnel,  high  purity
chemicals and proper maintenance.  Pharmaceutical industry's  main role in quantitative
chemical analysis to ensure that the raw materials used and the final product obtained
meets the required specifications or not.
3.1. Aim
The aim of the present work was to develop and validate a new simple, precise,
accurate,  and reliable RP-HPLC method for the simultaneous estimation of  Alogliptin
and Metformin HCl bulk and Pharmaceutical dosage form. 
3.2. Objective
The  literature  survey  reveals  that  there  are  several  methods  reported  for  the
estimation of Alogliptin and Metformin HCl alone or in combination with other drugs in
their pharmaceutical dosage forms but none of the method available for the estimation of
these drugs in the selected pharmaceutical dosage form.
In  the  analysis  of  formulations  containing  two  or  more  drugs,  one  drug  can
interfere  in  the  estimation  of  another  drug.  To  avoid  this,  separation  of  component
mixture by extraction is usually carried out which make the procedure time consuming
and  complicated  and  often  lacks  accuracy.  Therefore,  it  was  thought  worthwhile  to
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develop such a method of analysis, which can estimate both the drugs in combination
without prior separation.
Hence on the basis of the literature survey, it was thought to develop a precise,
accurate, simple and reliable method for estimation of drug in tablets using the following
technique of RP HPLC method for Alogliptin and Metformin HCl
3.3. Plan of work 
 Literature collection.  
 Study of physicochemical properties of drug (pH, pKa and solubility).
 Procurement of chemicals and API.
 Selection of suitable solvent.
 Selection of suitable wavelength.
 Development of RP-HPLC method for the quantification of Alogliptin benzoate
and Metformin HCl in bulk and pharmaceutical dosage form.
 Validation of proposed method as per ICH Q2 (R1) guidelines.
 Estimate  the  amount  of  Alogliptin  benzoate  and  Metformin  HCl  in  bulk  and
pharmaceutical dosage form.
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4. DRUG PROFILE
4.1. Alogliptin benzoate [38-43]
Synonyms: 
2-[[6-[(3R)  -3-Amino-1-piperidinyl]  -3,4-dihydro-3-methyl-2,4-dioxo-1  (2H)
-pyrimidinyl] methyl] benzonitrile.
IUPAC Name:
2-({6-[(3R) -3-aminopiperidin-1-yl] -3-methyl-2,4-dioxo-3,4- dihydropyrimidin-1
(2H) - yl} methyl) benzonitrile.
 Structural Formula:
Chemical Formula: 
C25H27N5O4
Molecular Mass: 
461.513
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Description: 
Alogliptin  benzoate is  a  white to  off-white,  crystalline powder containing one
asymmetric carbon in the aminopiperidine moiety. 
Solubility: 
It  is  soluble  in  dimethylsulfoxide,  sparingly  soluble  in  water  and  methanol,
slightly soluble in ethanol, and very slightly soluble in octanol and isopropyl acetate.
Melting point: 
127-129°C
Category: 
Dipeptidyl peptidase 4 (DPP-4) Inhibitor
Storage:  
Store it at room temperature between (20°C to 25°C). 
Mechanism of Action: 
Alogliptin inhibits dipeptidyl peptidase 4 (DPP-4), which normally degrades the
incretins glucose-dependent insulinotropic polypeptide (GIP) and glucagon like peptide 1
(GLP-1).  The inhibition of  DPP-4 increases  the amount of active plasma increments,
which  helps  with  glycemic  control.  GIP  and  GLP-1  stimulate  glucose  dependent
secretion  of  insulin  in  pancreatic  beta  cells.  GLP-1  has  the  additional  effects  of
suppressing  glucose  dependent  glucagon  secretion,  inducing  satiety,  reducing  food
intake, and reducing gastric emptying.
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Side Effects:  
Alogliptin  is  an  anti-diabetic  drug  used  as  an  adjunct  to  diet  and  exercise  to
improve glycemic control in adults with type 2 diabetes mellitus. It should not be used in
patients  with  type  1  diabetes  mellitus  or  for  the  treatment  of  diabetic  ketoacidosis.
Common side effects include sore throat, sinus infection, or headache.
Use:
Oral antihyperglycemic drugs used to treat type 2 diabetes. 
Dose:
12.5 mg.
Brand name: 
Kazano. 
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4.2. Metformin HCl [27-37]
Synonyms: 
1,1-Dimethylbiguanide  hydrochloride,  N,N-Dimethylimidodicarbonimidic
Diamide  Hydrochloride;  Diabetosan;  Diabex;  Glucophage;  Metiguanide;  Glucoform;
Glucomet; Glucomin; Glucomine; Orabet; Siamformet; Walaphage.
IUPAC Name:
 1-carbamimidamido- N, N-dimethyl methanimidamide 
Structural Formula: 
         
Chemical Formula: 
C4H11N5•HCl
Molecular Mass: 
165.63.  
Description: 
Metformin hydrochloride is a white to off-white crystalline powder.
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Solubility: 
Metformin hydrochloride is freely soluble in water and is practically insoluble in
acetone, ether, and chloroform.
Melting point: 
222 °C to 226 °C.
Category: 
Non-insulin-dependent diabetes mellitus (NIDDM)
Storage:  
2-8°C 
Mechanism of Action: 
Metformin's  mechanisms  of  action  differ  from  other  classes  of  oral
antihyperglycemic  agents.  Metformin  decreases  blood  glucose  levels  by  decreasing
hepatic glucose production, decreasing intestinal absorption of glucose, and improving
insulin sensitivity by increasing peripheral glucose uptake and utilization. These effects
are  mediated  by the  initial  activation  by metformin of  AMP-activated  protein  kinase
(AMPK), a liver enzyme that plays an important role in insulin signaling, whole body
energy balance, and the metabolism of glucose and fats. Activation of AMPK is required
for metformin's inhibitory effect on the production of glucose by liver cells. Increased
peripheral  utilization  of  glucose  may  be  due  to  improved  insulin  binding  to  insulin
receptors.  Metformin administration also increases  AMPK activity in skeletal  muscle.
AMPK is known to cause GLUT4 deployment  to the plasma membrane,  resulting in
insulin-independent glucose uptake. The rare side effect, lactic acidosis, is thought to be
caused  by  decreased  liver  uptake  of  serum  lactate,  one  of  the  substrates  of
gluconeogenesis. In those with healthy renal function, the slight excess is simply cleared.
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However,  those  with  severe  renal  impairment  may  accumulate  clinically  significant
serum lactic  acid  levels.  Other  conditions  that  may precipitate  lactic  acidosis  include
severe hepatic disease and acute/decompensated heart failure. 
Side Effects:  
Headache, dizziness, nervousness, depression, drowsiness, insomnia, vertigo and
ringing in the ear, Chest pain, high blood pressure and fluid retention
Use:
Oral antihyperglycemic drugs used to treat type 2 diabetes.
Dose: 
500mg.
Brand name:
Kazano.
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5. MATERIALS AND METHODS
5.1. Equipments used: 
 Table - 3: Equipment
Name Make/Model
Analytical Balance Elico.
PH meter Metler Toledo.
Ultra sonicator Bandelin.
HPLC instrument Shimadzu,  LC-10AT-vp Solvent delivery system (pump), 
Detector Shimadzu, SPDM – 10AVP photodiode 
array detector.
Column
Phenomenex C
 
18 column 
(150x4.6mm, 5µm).
UV-VIS 
Spectrophotometer Schimadzu, SPD-2350A; LC solution.
5.2. Drugs and chemicals used:
5.2.1. Drug sample:
Table - 4: Drug samples
S.No Drug Samples Manufacturer/Supplier
1 ALogliptin Benzoate
Jinlan Pharm-Drugs 
Technology co., 
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Ltd.,
2 ALogliptin AN therapeutics
3 Kazano Purchased from the  Market
5.2.2. Reagents and chemicals:
Table - 5: Reagents and Chemicals
S. No NAME MAKE/GRADE
1 Methanol Merck (AR-Grade)
2 Acetonitrile Merck (AR-Grade)
3 Water Milli – Q -Water
4 Di – Sodium Hydrogen ortho Phosphate  (ARGrade)
S.D fine chemical Pvt
Ltd.,
5 Ortho phosphoric acid (AR Grade) S.D fine chemical PvtLtd.,
5.3. Methodology
5.3.1. Method development
5.3.1.1. Selection of wavelength (λmax)
The sensitivity of the HPLC method that uses PDA detection depends upon the
proper selection of the wavelength. An ideal wavelength is one that gives good response
for the drugs to be detected.
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ALogliptin and Metformin HCL in Methanol, were scanned in the UV-Visible
range of 200 to 400 nm against blank separately (Figure 9). Then suitable wavelength for
the detection of ALogliptin and Metformin HCl was selected at 249nm by overlapping
the spectrum of both the drugs. 
 
Figure  - 9: UV spectrum of Alogliptin Benzoate and Metformin HCl
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5.3.1.2. Trials for RP- HPLC method development
Trial – 1 
Chromatographic conditions
HPLC : Shimadzu,LC-10AT-vp Solvent delivery system.
Column : Phenomene x C
 
18 column (150x4.6mm, 5µm).
Flow Rate : 1.0 ml/min
PDA Detection : 249 nm
Injection Volume : 20 µL
Temperature         : 25oC
Run Time             : 20 min.
Mobile phase      : Methanol: Water (50:50 )  
Diluent               : Mobile phase.
Result:
More noise peaks are observed and drug is not eluted (Chromatogram no. 2).
J. K. K. Nattraja College of Pharmacy 52
Department of Pharmaceutical Analysis                                          Materials and Methods
Trial – 2
Chromatographic conditions
HPLC : Shimadzu, LC-10AT-vp Solvent delivery system.
Column : Phenomene x C
 
18 column (150x4.6mm, 5µm).
Flow Rate : 1.0 ml/min.
PDA Detection : 249 nm.
Injection Volume : 20 µL
Temperature         : 25oC.
Run Time             : 20 min.
Mobile phase : Methanol: Water (60:40).
Diluent : Mobile phase.
Result:
More  noise  peaks  are  observed  and  eluted  peaks  are  broad  in  shape
(Chromatogram no. 2).
J. K. K. Nattraja College of Pharmacy 53
Department of Pharmaceutical Analysis                                          Materials and Methods
Trial – 3
Chromatographic conditions
HPLC : Shimadzu, LC-10AT-vp Solvent delivery system.
Column : Phenomene x C
 
18 column (150x4.6mm, 5µm).
Flow Rate : 1.0 ml/min.
PDA Detection : 249 nm.
Injection Volume : 20 µL
Temperature         : 25oC.
Run Time             : 20 min.
Mobile phase : Buffer: Methanol (50:50); pH 4.5.  
Diluent : Mobile phase.
 
Result:
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ALogliptin and Metformin HCL peaks are elated, but peak shape is not good, and 
failed in theoretical plates, Tailing factors and also Retention time of both peaks are more
than 7 minutes (Chromatogram no. 3).  
Trial – 4
Chromatographic conditions
HPLC : Shimadzu, LC-10AT-vp Solvent delivery system.
Column : Phenomene x C
 
18 column (150x4.6mm, 5µm).
Flow Rate : 1.0 ml/min.
PDA Detection : 249 nm.
Injection Volume : 20 µL.
Temperature         : 25oC.
Run Time             : 20 min.
Mobile phase : Buffer : methanol (40:60); pH- 4.
Diluent : Mobile phase.
 
Result:
J. K. K. Nattraja College of Pharmacy 55
Department of Pharmaceutical Analysis                                          Materials and Methods
ALogliptin and Metformin HCL peaks are elated, but failed in tailing factor and 
also retention time both peaks are being more (Chromatogram no. 4).
Trial – 5
Chromatographic conditions
HPLC : Shimadzu, LC-10AT-vp Solvent delivery system.
Column : Phenomene x C
 
18 column (150x4.6mm, 5µm).
Flow Rate : 1.0 ml/min.
PDA Detection : 249 nm.
Injection Volume : 20 µL.
Temperature         : 25oC.
Run Time             : 10 min.
Mobile phase : Buffer : Methanol and (35:65); pH 3.5.
Diluent : Mobile phase.
Result:
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Peaks are elated nicely and passed in all the efficiency parameters, but sharp 
peaks will not be appearing (Chromatogram no. 5). 
Trial – 6
Chromatographic conditions
HPLC : Shimadzu, LC-10AT-vp Solvent delivery system.
Column : Phenomene x C
 
18 column (150x4.6mm, 5µm).
Flow Rate : 1.2 ml/min.
PDA Detection : 249 nm.
Injection Volume : 20 µL.
Temperature         : 25oC.
Run Time             : 4 min.
Mobile phase : Buffer: ACN:Methanol (30:5:650), pH- 3.5.  
Diluent : Mobile phase.
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Result:
Metformin and ALogliptin are eluted at 2.078 and 3.238 respectively, efficiency
parameters are indicate the good separation, asymmetric. So this method was selected for
further analysis (Chromatogram no. 6).
5.4. Validation of developed method: 
The developed method was validated according to ICH [11-16] guidelines. 
5.5. Preparation of solutions
5.5.1. Preparation of phosphate buffer solution
4.2568 gm of di-sodium hydrogen orthophosphate was weighed and sufficient 
water (HPLC grade) was added to dissolve it. Then sonicate for 10 min. Then 1ml of tri 
ethanol amine was added, the final volume was made up to 1000ml with water and 
adjusted the pH to 3.5 with ortho phosphoric acid.
5.5.2. Preparation of mobile phase:
Methanol,  Buffer  and Acetonitrile  were  mixed  in  the  ratio  of  65:30:5  and
sonicated for 20minutes, Filtered with 0.45 µ membrane filter.
5.5.3. Preparations of working standard solution:
500mg of Metformin HCL and 12.5 mg of Alogliptin were accurately weighed
and transferred in to a separate 50 ml volumetric flask and sufficient mobile phase was
added to dissolve the drug.  The final volume was made up to 50 ml with mobile phase
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(primary stock solution).  Pipette  out  2ml  from the  above stock solution  into  a  50ml
volumetric flask and the final volume was made up to the mark with the mobile phase.
5.5.4. Preparation of Sample solution
20 tablets were weighed and powdered, tablets powder equivalent to 500mg of
Metformin HCL and 12.5mg of  ALogliptin  was transferred  in to a  50 ml volumetric
flask,  sufficient  amount  of  mobile  phase  was  added  and  dissolved  by  20  minutes
ultrasonication. Then made the volume up to the mark with the mobile phase and filtered
with 0.45 µ filter paper. Pipette out 2 ml from the above solution and diluted to 50ml with
the mobile phase.
The amount of Metformin HCl and Alogliptin present in each tablet were calculated by
using the following formula:
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6. Results and Discussion
6.1. Validation of developed method: 
The developed method was validated according to ICH [13] guidelines. The method
was validated in terms of specificity,  system suitability,  linearity,  precision,  accuracy,
robustness, LOD and LOQ. 
6.1.2. Specificity:
The specificity of the method was established by injecting the blank  and standard
solution. It is observed that there is no interference of the blank (Chromatogram no. 7)
with principal peaks (Chromatogram no. 8), hence the method was specifically for these
two drugs.
6.1.2. System suitability:
The  working  standard  solution  was  injected  5  times  into  the  HPLC,
chromatograms were recorded and measured the responses for the major peaks.  System
suitability parameters such as retention time, theoretical  plates and asymmetric  factor.
Then the percentage of RSD of all the parameters were calculated and presented in the
table 6  the percentage RSD.
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Table – 6: System suitability parameters
MET
Area
ALG
Area
MET
Theoretical
plates
ALG
Theoretical
plates
MET
Tailing
factor
ALG
Tailing
factor
4208745 400587 3568.305 4836.127 1.276 1.105
4208746 396574 3586.231 4836.241 1.285 1.118
4198754 398567 3528.97 4863.727 1.256 1.126
4184764 397854 3594.212 4758.963 1.274 1.113
4207841 399852 3567.422 4698.521 1.293 1.133
AVG 4201770 398686.8 3569.028 4798.716 1.2768 1.119
SD 10397.99 1592.19 25.1889 68.2888 0.01388 0.0109
%
RSD
0.247467 0.3993 0.7057 1.4230 1.0872 0.9769
6.1.3. Linearity: 
Appropriate  volume  from  the  stock  solution  was  diluted  to  get  the  final
concentration of 200, 300, 400, 500, 600 µg/mL for Metformin HCl and 5, 7.5, 10, 12.5,
15 µg/mL for Alogliptin. Then the chromatogram was recorded  (Chromatogram no. 9-
13)  for  each  concentration,  plot  the  graph  concentration  versus  area.  The  calibration
graph was shown in figure -10 and 11.
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Figure - 10: Calibration graph of Metformin HCl
Figure- 11: Calibration graph of Alogliptin
From the linearity study, Metformin HCl and ALogliptin were found to be linear
in the concentration range from 200 - 600 µg/ml and 5 - 15 µg/ml. Correlation coefficient
values  (R2) were  found  to  be  0.9993  and  0.9996  for  Metformin  HCl  and  Alogliptin
respectively. Results revealed that good correlation exists between the concentration of
the sample and their area.
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6.1.4. Precision:
 Precision  study  was  carried  out  by  injecting  a  sample  solution  in  to  HPLC
without changing the assay procedure and the results are shown the % RSD is   less than
2 % for metformin HCl and Alogliptin. The low RSD value indicated that the method
was precise.
6.1.4.1. Repeatability:
This study was performed with a minimum of three replicate measurements of
sample solution at 0 hrs, 8 hrs and 16 hrs in a same day.
6.1.4.2. Intermediate precision:
 Intermediate  precision  was  performed  by  injecting  the  sample  solution  in  to
HPLC at three different days, different analysts and in different instruments.
6.1.4.3. Reproducibility:
 Reproducibility  studies  were  done  in  two  laboratories  and  the  results  were
compared.
All the precision study results presented in the table 7 and chromatogram of this
study show chromatogram no 14 - 21.
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Table - 7: Precision results for MET and ALG
Parameters Sampling
time
MET ALG
Amount
present
(mg)
Amount
present
(%)
RSD
(%)
Amount
present
(mg)
Amount
present
(%)
RSD
%
Repeatability
0 hrs 495.11 99.02 0.0920 12.62 100.97 1.4542
8th hrs 499.69 99.93 0.9449 12.37 100.62 0.5498
16th hrs 503.98 100.79 0.3633 12.60 100.83 0.7566
Intermediate
precision
I st Day 504.63 100.92 0.4993 12.55 100.42 0.7712
2nd day 503.59 100.71 0.3197 12.63 101.06 0.6141
3rd day 497.53 99.50 0.1257 12.70 101.64 0.1250
Analyst -1 502.26 100.45 0.1907 12.63 101.07 0.8081
Analyst -2 504.35 100.87 0.1197 12.61 100.94 0.6498
Instrument
-1
501.00 100.20 0.7276 12.66 101.30 0.1559
Instrument
-2
504.86 100.97 0.1219 12.61 100.94 0.4287
6.1.5. Accuracy:
This study was performed using a minimum of 3 concentration levels, each in
triplicate determinations (Chromatogram no. 22-25).
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75, 100 and 125% from the label claim of metformin HCl and Alogliptin benzoate
was  taken  in  to  a  50  ml  volumetric  flask  and  sufficient  mobile  phase  was  added,
sonicated 20 min for dissolving the drugs, final volume was adjusted up to the mark with
the mobile phase. Pipette out 2 ml from the above solution into a 100 ml volumetric flask
and final volume was adjusted up to the mark with the mobile phase. Then chromatogram
(Chromatogram no. 14) was recoded in triplicate and the results are shown in table – 8.
Table - 8: Recovery results for MET and ALG
Concentration
(%)
Added AMT
amount
(mg)
Amt recovered
(mg)
Amt recovered
(%)
MET / ALG MET ALG MET ALG MET ALG
75 375 9.375 374.65 9.394 99.90 100.20
100 500 12.5 495.17 12.649 99.03 101.19
125 625 15.625 621.83 15.487 99.49 99.11
The percentage  recoveries  of  the  three concentrations  (75 %, 100% and 125%) were
found to be close to 100%, indicative of high accuracy of this method.
6.1.6. Robustness 
Robustness of the method were determined by changing the method parameters
(wavelength ± 1nm from 1nm, Flow rate ± 0.1 (Chromatogram no. 26,27), pH ± 0.05 and
the mobile phase ratio ± 2 %),  the results were presented in Table 11. Based on the
results of these studies show, the small changes made to the method procedure, but it will
not affect the method results so this method is robust.
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Table - 11: Results observed by changing the wavelength ± 1nm
MET ALG
Parameters Amount
present
(mg)
Amount
 present
(%)
RSD
%
Amount 
 present
(mg)
Amount
Present
(%)
RSD
%
Wavelength
(nm)
248 493.04 98.60 0.1139 12.64 101.16 0.0549
250 505.57 101.11 0.1237 12.63 101.11 0.0504
Flow Rate 
(mL/min)
1.3 502.87 100.57 0.3725 12.61 100.94 0.4278
1.1 502.90 100.58 0.7906 12.65 101.23 0.0153
Mobile 
phase (% 
of 
(Methanol)
67 502.99 100.59 0.3907 12.65 101.27 0.1750
63 504.86 100.97 0.09942 12.58 100.66 0.3853
pH 3.55 498.76 99.75 1.1828 12.64 101.18 0.0634
3.45 500.30 100.06 1.3808 12.63 101.08 0.0801
6.1.7. Limit of Detection (LOD) and Limit of Quantification (LOQ):
The  LOD  and  LOQ  of  the  developed  method  were  determined  by
analyzing progressively low concentration of the standard solution using the developed
methods. The LOD is the concentration of the analyte that gives a measurable response
(signal to noise ratio 3.3). The LOQ is the lowest concentration of the analyte,  which
gives a response that can be accurately quantified (signal to noise ratio of 10). LOD  and
LOQ of Metformin HCl and Alogliptin was found to be 359.561 ng/mL, 84.037 ng/mL
and 1.08958 ng/ml, 254.658 ng/m   (Table 12).
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Table – 12: LOD and LOQ
MET ALG
2056745 188634
2057246 187858
2058874 187658
SD 1113.106 515.5502
Slope 10215.91 20244.82
LOD (µg/mL) 0.359561 0.084037
LOQ (µg/mL) 1.08958 0.254658
6.1.8. Stability Studies:
      Stability of drug solution was determined by keeping the drug solution for 3
days  at  room  temperature.  The  chromatogram  was   recorded  by  injecting  the
sample solution at once per day and calculated the amount of drug present. There is
no significant  degradation was observed. The stability test results (Table 13) are
indicating the drug solutions are stable up to 3 days at room temperature. 
Table – 13: Stability studies
MET ALG
Parameters Amount
present
(mg)
Amount
 present
(%)
Amount 
 present (mg)
Amount
Present (%)
J.K.K. Nattraja College of pharmacy 67
Department of Pharmaceutical Analysis                                           Results and Discussion
Day 1 504 98.60 12.65 101.25
Day 2 504.38 100.87 12.64 101.17
Day 3 503.88 100.77 12.64 101.16
6.1.9.  Apply  the  developed  and  validated  method  for  the  estimation  of
Metformin HCl and Alogliptin in marketed tablet dosage form:
Sample solution was prepared according to the above described procedure.
Then  the  solution  was  injected  in  to  the  HPLC  and  calculated  the  amount  of
Metformin HCl, Alogliptin present in the each tablet by using the above mentioned
formula, results are present in the table – 14, 15 and Chromatogram no 28 - 30.
Table – 14: Assay results for MET
SAM Area STD Area Amt present % Amt present
4257964 4201770 501.7721 100.3544
4287561 4201770 505.2599 101.0517
4287956 4201770 505.3064 101.0612
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4281863 4201770 504.5884 100.9176
4178293 4201770 492.3834 98.4766
4187956 4201770 493.5221 98.7044
AVG 500.4721 100.0944108
SD 5.977577 1.195515343
% RSD 1.194388 1.194387712
Table – 14: Assay results for ALG
SAM Area STD Area Amt present % Amt present
403156 398687 12.54026 100.3220
406321 398687 12.63871 101.1096
403652 398687 12.55569 100.4454
406328 398687 12.63893 101.1114
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401357 398687 12.4843 99.8744
398741 398687 12.40293 99.2234
AVG 12.54347 100.3477463
SD 0.091207 0.729659142
% RSD 0.727131 0.727130573
The developed RP-HPLC method for simultaneous estimation of Metformin Hcl
and  Alogliptin  benzoate  in  combined  dosage  from  through  the  C18  column  and
Methanol: 30 mM of Di – sodium hydrogen ortho phosphate as mobile phase. Detection
of eluent carried out using a UV detector at 249 nm. The run time per sample is just 4
min. The excipients in the formulation did not interfere in the accurate estimation of
metformin  HCL  and  ALogliptin  benzoate.  The  method  was  validated  as  per  ICH
guidelines in terms of linearity, accuracy, specificity, precision, and robustness. Since this
developed method can be used for routinely for the analysis of these drugs.
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7. CHROMATOGRAMS
CHROMATOGRAM NO 1: TRAIL -1
CHROMATOGRAM NO 2: TRAIL -2
CHROMATOGRAM NO 3: TRAIL -3
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CHROMATOGRAM NO 4: TRAIL - 4
CHROMATOGRAM NO 5: TRAIL -5
CHROMATOGRAM NO 6: TRAIL -6
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CHROMATOGRAM NO 7: STD -1
CHROMATOGRAM NO 8: STD -2
CHROMATOGRAM NO 9: STD -3
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CHROMATOGRAM NO 10: STD -4
CHROMATOGRAM NO 11: STD -5
CHROMATOGRAM NO 12: METFORMIN HCl
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CHROMATOGRAM NO 13: ALOGLIPTIN BENZOATE
CHROMATOGRAM NO 14: LENIEARITY -1
CHROMATOGRAM NO 15: LENIEARITY -2
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CHROMATOGRAM NO 16: LENIEARITY -3
CHROMATOGRAM NO 17: LENIEARITY – 4
CHROMATOGRAM NO 18: LENIEARITY - 5
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CHROMATOGRAM NO 19: PRECISION  0HRS
CHROMATOGRAM NO 20: PRECISION  8HRS
CHROMATOGRAM NO 21: PRECISION  16HRS
J.K.K. Nattraja College of Pharmacy 77
Department of Pharmaceutical Analysis                                                           Chromatograms
CHROMATOGRAM NO 22: PRECISION  DAY -1-1
CHROMATOGRAM NO 23: PRECISION  DAY -1-2
CHROMATOGRAM NO 24: PRECISION  DAY -1-3
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CHROMATOGRAM NO 25: PRECISION  DAY -2-1
CHROMATOGRAM NO 26: PRECISION  DAY -2-2
CHROMATOGRAM NO 27: PRECISION  DAY -2-3
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CHROMATOGRAM NO 28: PRECISION  DAY -3-1
CHROMATOGRAM NO 29: PRECISION  DAY -3-2
CHROMATOGRAM NO 30: PRECISION  DAY -3-3
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CHROMATOGRAM NO 31: PRECISION  DAY –INSTRUMENT –I
CHROMATOGRAM NO 32: PRECISION  DAY –INSTRUMENT –II
CHROMATOGRAM NO 33: PRECISION  DAY –ANALYST –I
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CHROMATOGRAM NO 33: PRECISION  DAY – ANALYST –II
CHROMATOGRAM NO 34: ACCURACY -  75%
CHROMATOGRAM NO 35: ACCURACY -  100%
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CHROMATOGRAM NO 36: ACCURACY -  125%
CHROMATOGRAM NO 37: ROBUSTNESS – FLOW RARE – 0.1 mL/min
CHROMATOGRAM NO 38: ROBUSTNESS – FLOW RARE + 0.1 mL/min
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CHROMATOGRAM NO 39 : ROBUSTNESS – MOBILE PHASE – 2  %
CHROMATOGRAM NO 40: ROBUSTNESS – MOBILE PHASE + 2 %
CHROMATOGRAM NO 41: ASSAY
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8. Conclusion 
The  developed  RP-HPLC  method  was  specific,  simple,  sensitive,  precise,
accurate and robust, for the detection of Metformin HCL and Alogliptin benzoate in pure
and pharmaceutical dosage form. The proposed method is quite simple and do not require
any pretreatment of the drug and tedious extraction procedure. The method has a wider
linear dynamic range with good accuracy and precision. So the proposed method is used
for the routine analysis of  Metformin HCL and Alogliptin benzoate in pharmaceutical
quality control.
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